High-Performance B2B Supply for New Zealand Medical Wholesalers & Infectious Disease Specialists Sky High Medex is a specialized pharmaceutical exporter providing Azimax 250 Tablets to licensed medical importers, distributors, and specialized clinical facilities across New Zealand. Manufactured by Cipla Ltd, a globally recognized leader in pharmaceutical excellence, Azimax contains Azithromycin (250mg), a potent macrolide antibiotic utilized in professional clinical environments for the management of a wide range of bacterial infections.
B2B Order Specifications:
Minimum Order Quantity (MOQ): 500 Tablets (Strictly Wholesale).
Active Ingredient: Azithromycin 250mg.
Manufacturer: Cipla Ltd.
Therapeutic Class: Macrolide Antibiotic (Azalide subclass).
Format: Film-Coated Tablet.
The Sky High Medex Advantage for New Zealand Buyers:
Competitive B2B Pricing: Source directly from India to optimize procurement margins for your medical facility, specialized pharmacy, or distribution network in Auckland, Wellington, or Christchurch.
Cipla Quality Assurance: Access a premium formulation produced under rigorous international quality controls, ensuring the chemical stability, potency, and strict quality standards required for institutional use.
Verified Export Authority: We operate with a registered Import-Export Code (IEC) and GST registration, providing a 100% legal and verifiable trade trail for professional auditing and international compliance.
Comprehensive Documentation: Every shipment includes the Certificate of Analysis (COA), GST-compliant invoices, and detailed packing lists to support institutional compliance and inventory management.
Logistics & New Zealand Customs Support: While New Zealand importers are responsible for domestic compliance (including Medsafe regulations) and customs clearance, Sky High Medex handles all Indian export formalities with precision. We offer fast air-freight shipping to major New Zealand hubs, including Auckland (AKL) and Christchurch (CHC), ensuring your bulk order is handled with professional care.
Technical Insight & Clinical Applications: Azimax 250 (Azithromycin 250mg) is a cornerstone in modern antibiotic therapy. In the New Zealand clinical context, it is recognized for:
Mechanism of Action: Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of susceptible microorganisms, effectively preventing the translocation of peptides.
Clinical Utility: Specifically indicated for the treatment of community-acquired pneumonia, acute bacterial sinusitis, uncomplicated skin and soft tissue infections, and certain sexually transmitted infections (STIs) caused by Chlamydia trachomatis.
Pharmacokinetic Profile: Characterized by rapid distribution into tissues and high intracellular concentrations. Its exceptionally long terminal elimination half-life allows for shortened, convenient dosing regimens (e.g., 3-day or 5-day courses).
High Tissue Affinity: Due to its unique distribution, therapeutic concentrations remain at the site of infection for several days after the final dose is administered, enhancing efficacy and patient adherence.
👉
📦 Request a Wholesale Quote for New Zealand Contact our export desk today for current batch availability and tiered pricing.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk
